Kairos Pharma, Ltd. filed a Form 8-K on November 5, 2026, disclosing that the company has been named a winner of the 2026 Biotech Breakthrough Awards in the category of Cancer Immunology Solution of the Year for its work with ENV-105 (carotuximab).
Digital Turbine, Inc. filed a Form 8-K on November 5, 2026, disclosing the appointment of Daniel Lentz as Chief Financial Officer, effective November 2, 2026, along with the terms of his employment agreement and equity awards.
Liberty Media Corporation filed a Form 8-A on November 5, 2026, registering Preferred Stock Purchase Rights on The Nasdaq Stock Market LLC following the Board's adoption of a Rights Agreement dated November 4, 2026.
John C. Malone filed Amendment No. 11 to Schedule 13D with the SEC on November 5, 2026, disclosing that he ceased to be the beneficial owner of more than five percent of Liberty Media Corporation's Series B common stock as of November 4, 2026.
Criteo S.A. filed a Definitive Proxy Statement (DEFM14A) on November 5, 2026, seeking shareholder approval to merge the company's Luxembourg entity into its wholly owned Delaware subsidiary, Criteo Holdings, Inc., as part of a redomiciliation to the United States.
BHAV Acquisition Corp filed a Form 8-K on November 5, 2026, disclosing that it has entered into a definitive business combination agreement with Nemi Corp., a physical AI and manufacturing company, through which Nemi is expected to become a publicly traded company.
C3is Inc. filed a Form 6-K with the SEC on November 5, 2026, announcing a one-for-five reverse stock split of its common stock set to take effect at 11:59 pm Eastern Time on November 8, 2026.
The New York Stock Exchange filed a notification on November 5, 2026, to remove Cadeler A/S's American Depositary Shares from listing and registration under Section 12(b) of the Securities Exchange Act of 1934.
Dai Kun, Chief Executive Officer and Director of Uxin Ltd, filed a Form 4 on November 5, 2026, disclosing purchases of American depositary shares on November 3 and November 4, 2026, executed pursuant to a Rule 10b5-1(c) plan.
BHAV Acquisition Corp filed a Form 8-K on November 5, 2026, disclosing that it has entered into a definitive business combination agreement with Nemi Corp., a physical AI and manufacturing company, through which Nemi is expected to become a public company.